Drovix.
Brutalist concrete transit hall at dawn, two parallel illuminated conveyor tracks running
Education

Switching Liquidity Providers Without Breaking Execution Quality

A practical playbook for migrating wholesale FX/CFD liquidity providers — parallel running, dark-launch percentages, fill-quality cohorts, and the eight failure modes nobody warns you about.

HomeResourcesInsights & News
25 May 2026Drovix Research Desk10 min

Migrating a wholesale liquidity provider is one of the riskiest operational changes a broker can make. It is also one of the most under-rehearsed. Most teams treat it like an IT cutover — flip the connection, monitor for an afternoon, declare success — and only notice the damage two months later when the P&L review shows fill ratio is down four points and average spread is up six tenths.

This article is the migration playbook we use when we onboard new counterparties at Drovix. It assumes you are switching from any wholesale provider to any other wholesale provider; the principles are vendor-agnostic.

Why migrations fail

Liquidity is a moving target. Your incumbent's quality at the moment you signed is not their quality today, and the new provider's pitch deck is a curated snapshot. The only honest comparison is real flow, matched cohort, over a representative window. That requires planning the migration as an experiment, not a deployment.

The eight failure modes

  • 1. Comparing aggregate metrics instead of matched cohorts.
  • 2. Migrating during an atypical market regime (post-NFP week, holiday liquidity).
  • 3. Not isolating last-look policy differences in the comparison.
  • 4. Underestimating the credit-line setup timeline and ending up with a hybrid book during stress.
  • 5. Switching FIX session parameters mid-test (e.g., heartbeat interval, MaxMessagesPerSecond).
  • 6. Forgetting that drop-copy and audit trail change shape — your reconciliation breaks silently.
  • 7. Not running the rollback drill before go-live.
  • 8. Communicating the cutover to clients (downstream brokers) too late, or not at all.
Abstract parallel-run comparison chart: two overlapping price ribbons (cool cyan and warm
Abstract parallel-run comparison chart: two overlapping price ribbons (cool cyan and warm

Phase 1 — RFP and shortlisting

Limit the shortlist to three. More than three and the decision becomes political. Build the RFP against the twelve questions in our buyer's guide, weight them by what actually matters for your book, and score each candidate blindly. Do not let a relationship manager tell you `we will price that better in production' — anything not in the RFP response is not real.

Phase 2 — Contracting and credit

Contracting takes longer than people expect because credit and KYC run in parallel and either can block. Start collateral wiring early. If you are switching to a pre-funded model from a credit-line model (or vice versa), model the capital impact for at least a full quarter; it is not unusual for the working-capital change to be the biggest single line item in the migration.

Phase 3 — Technical certification

Standard FIX certification covers logon, order entry, cancel/replace, partial fills, and drop-copy. What is usually missed:

  • Burst behaviour at 10x normal message rate.
  • Behaviour when the primary session is up but stale (heartbeat fine, no quotes).
  • Failover to secondary venue mid-trade.
  • Symbol mapping for any non-standard tickers (especially exotic FX and index CFDs).
  • Time-in-force interactions with rollover windows.

Phase 4 — Parallel running

This is the single most important phase, and the one most often skipped. Connect to the new provider in production, but route a controlled percentage of flow — start at 5% — and replicate that flow against the incumbent's quote stream at the same instant. You are not actually executing against both; you are recording the prices and comparing what would have happened.

After two weeks of parallel data, you have matched-cohort fill quality, matched-cohort effective spread, and last-look reject rates that are directly comparable. Reject any provider that refuses to support a parallel period — that refusal is itself the answer.

Abstract migration ramp diagram: five ascending step blocks transitioning gradient from co
Abstract migration ramp diagram: five ascending step blocks transitioning gradient from co

Phase 5 — Staged cutover

Migrate one asset class at a time. The standard sequence is:

  • Week 1: Move the asset class with the largest execution gap (where the new provider looks meaningfully better).
  • Week 2: Move secondary asset classes once stability is observed.
  • Week 3: Move benchmarks (EUR/USD, USD/JPY, XAU/USD) — the ones that matter most for your monthly report.
  • Week 4: Decommission the incumbent for migrated instruments, keep them warm on the long tail until you are 60 days past cutover.

Phase 6 — Rollback drill

Before going live, run the rollback drill. In UAT, simulate the scenario where the new provider has a 30-minute outage during the London open. You should be able to fail back to the incumbent within five minutes without manual intervention. If that is not true, you do not have a migration plan — you have a leap of faith.

After go-live — the 90-day review

Lock in a formal 90-day execution review. Compare like-for-like quarters. The numbers that matter, in order: fill ratio at notional aggressor cohorts, effective spread by time-of-day bucket, last-look reject rate by venue, average latency at the 95th percentile, and post-trade reconciliation break rate.

If any of those numbers regressed and you cannot explain why, do not normalise it. Either find the cause or roll back. The cost of a second migration is high but it is finite; the cost of slowly bleeding execution quality is unbounded.

Migrating to Drovix specifically

Drovix supports a structured parallel-running mode out of the box. We will give you a shadow FIX session that receives a copy of every quote and computes a what-if fill against your actual ticket stream, so you can build the cohort comparison without any production risk.

If you want to see a sample parallel-run report from a recent migration (anonymised), the institutional sales desk will send one on request.

Analyst Desk

Drovix Research Desk

Institutional Research

Drovix Research Desk publishes institutional-grade analysis covering macro events, cross-asset correlations, and execution insights for professional market participants.

Frequently Asked Questions

Q1.How long does a typical LP migration take?+
End-to-end, 8–14 weeks for a multi-asset broker: 2 weeks RFP, 1–2 weeks contracting, 3 weeks technical certification, 2 weeks parallel running, and 2–3 weeks of staged cutover. Compressing this aggressively is the most common cause of execution degradation post-migration.
Q2.Should I switch all instruments at once?+
No. Migrate one asset class at a time, starting with the one where your incumbent's execution is weakest. EUR/USD is usually a bad first instrument because it is everyone's reference benchmark — pick something where you have headroom on fill quality.
Q3.What is a `dark launch' in liquidity terms?+
Routing a small percentage (typically 5–20%) of live flow through the new LP while keeping the rest on the incumbent, then comparing fill quality on matched-cohort tickets. The flow is real — it is not synthetic — but the share is bounded so a bad day does not blow up the book.
Q4.What is the most common failure mode?+
Comparing aggregate spread instead of cohort-matched spread. A new LP can look better on average simply because your flow happened to hit easier sessions during the test window. Always match cohorts by time-of-day, instrument, notional bucket, and aggressor side before drawing conclusions.

Related Reads

Education

TCA That Actually Drives Decisions: Beyond Implementation Shortfall

Next Read

Education

From RFP to First Fill: A 6-Week Liquidity Onboarding Playbook

Next Read

Education

The True Cost of Institutional Liquidity: Beyond the Quoted Spread

Next Read

Back to Insights
Drovix.

Institutional-grade liquidity, connectivity, and analytics for professional market participants worldwide.

About

  • Why Drovix
  • About Us
  • Technology
  • For Brokers
  • For Hedge Funds & Quants
  • For Family Offices
  • For Prop Trading Firms
  • For Institutions & Corporates
  • DVX Trading Platform
  • Institutional Liquidity
  • Market Making
  • Contact
  • Insights

Compliance

  • Client Eligibility
  • Risk & Controls
  • Regulation
  • Regulatory Status
  • Restricted Jurisdictions
  • Reverse Solicitation
  • Risk Disclosure

Legal

  • Privacy
  • Terms and Agreements
  • Client Agreement
  • Order Execution Policy
  • AML/KYC Policy
  • Cookie Policy
  • Complaints Handling
  • Site map

Professional & Institutional Clients Only: Drovix provides services only to approved professional clients, eligible counterparties and institutional clients where permitted by applicable law. Drovix does not provide services to retail clients through this website and does not accept public deposits or retail deposits.

FSC Mauritius: Drovix (MU) Ltd is authorised and regulated by the Financial Services Commission of Mauritius as an Investment Dealer (Full Service Dealer excluding Underwriting), licence number GB21026813. Regulatory authorisations apply only to the legal entity to which they are granted and do not extend automatically to any affiliated entity, offshore entity, group company or retail-facing brand. Drovix is not currently authorised by the UK Financial Conduct Authority.

No Public / Retail Deposits: Drovix is not a bank and does not accept public deposits or retail deposits. Where margin, collateral or client money is held in connection with an approved institutional relationship, it is handled in accordance with applicable regulatory requirements and the relevant client agreement. Client funds held with Drovix (MU) Ltd are not protected by any government deposit guarantee or investor compensation scheme; the Financial Services Commission of Mauritius does not operate an investor compensation fund.

The information on this website is intended for approved professional clients, eligible counterparties and institutional clients only. It does not constitute investment advice, a solicitation or a recommendation to enter into any transaction. Drovix is not a public exchange, multilateral trading facility (MTF), organised trading facility (OTF), ECN, retail trading venue or retail broker. Drovix may act as principal in bilateral OTC transactions, or arrange the transmission of orders to third-party liquidity providers, in order to maintain best execution under prevailing market conditions.

Reverse Solicitation Notice: The information and services on this website are not directed at or intended for distribution to residents or nationals of any country or jurisdiction where such distribution or use would be contrary to local law or regulation. Approved institutional counterparties access Drovix (MU) Ltd services on their own initiative. Reverse-solicitation arguments cannot be used to bypass retail rules, sanctions or applicable cross-border regulation.

Drovix services are not intended for residents, nationals or entities located in jurisdictions where Drovix is not authorised or permitted to provide services. Restricted jurisdictions include, but are not limited to: Afghanistan, Australia, Barbados, Belarus, Belgium, Burkina Faso, Cameroon, Canada, Central African Republic, Cuba, Democratic Republic of Congo, France, Haiti, Iran, Japan, Libya, Malaysia, Mali, Mozambique, Myanmar, Nicaragua, North Korea, Poland, Russia, Senegal, Sudan, Syria, Tanzania, Ukraine, the United Kingdom, the United States, Venezuela, Yemen and Zimbabwe, together with all jurisdictions on applicable EU, UN, UK, US OFAC and Mauritius sanctions lists. See Restricted Jurisdictions for the full list and policy.

© 2026 Drovix (MU) Ltd. All rights reserved.

Drovix (MU) Ltd is authorised and regulated by the Financial Services Commission (FSC) of Mauritius as an Investment Dealer (Full Service Dealer) under licence number GB21026813.

Drovix (MU) Ltd is not authorised by the United Kingdom Financial Conduct Authority and is not registered with the U.S. SEC, CFTC or NFA. Nothing on this website constitutes a financial promotion under section 21 of the UK Financial Services and Markets Act 2000.

The company operates under drovix.com and is registered at C/o SALVUS (Mauritius) Ltd, Silver Bank Tower, Ground Floor, 18 Bank Street, Cybercity, Ebene 72201 Mauritius.